Table 3—

Hemodynamic and renal parameters during placeboRS and placeboLS

ParameterPlaceboRS
PlaceboLS
Δ PlaceboLS − Δ placeboRS
P
Week 2Week 4Δ Week 4–2Week 2Week 4Δ Week 4–2Δ
Blood pressure (mmHg)
 24-h
  Systolic138.6 ± 4.2137.5 ± 4.0−1.1 ± 2.1131.9 ± 4.5132.6 ± 4.60.7 ± 2.71.8 (−5.9 to 9.5)NS
  Diastolic81.9 ± 3.180.9 ± 2.7−1 ± 1.177.3 ± 1.979.6 ± 2.72.3 ± 1.93.3 (−1.7 to 8.3)NS
  Mean arterial pressure100.8 ± 2.9100.4 ± 2.8−0.4 ± 1.597.5 ± 2.997.0 ± 2.8−0.5 ± 2.0−0.1 (−5.9 to 5.7)NS
 Awake
  Systolic141.8 ± 4.4141.5 ± 4.1−0.3 ± 2.4135.1 ± 4.7135.1 ± 4.80 ± 2.70.3 (−7.9 to 8.5)NS
  Diastolic84.2 ± 3.383.4 ± 2.7−0.8 ± 1.382.3 ± 3.081.7 ± 2.9−0.6 ± 1.80.2 (−4.6 to 5.0)NS
  Mean arterial pressure103.2 ± 3.2103.1 ± 2.9−0.1 ± 1.8100.3 ± 3.098.9 ± 3.1−1.4 ± 2.2−1.3 (−7.7 to 5.1)NS
 Sleep
  Systolic124.8 ± 4.1122.2 ± 3.6−2.6 ± 2.4121.0 ± 4.1122.4 ± 3.81.4 ± 3.04.0 (−3.7 to 11.7)NS
  Diastolic72.4 ± 3.371.4 ± 2.4−1.0 ± 1.767.8 ± 1.972.1 ± 2.94.3 ± 2.55.3 (−2.0 to 12.6)NS
  Mean arterial pressure93.3 ± 3.189.7 ± 2.5−1.6 ± 1.488.1 ± 2.589.4 ± 2.51.3 ± 2.12.9 (−3.3 to 9.1)NS
GFR (ml · min−1 · 1.73 m−2)100.7 ± 5.4100.5 ± 4.0−0.2 ± 2.199.0 ± 4.795.0 ± 4.6−4.0 ± 2.0−3.8 (−9.4 to 1.9)NS
MAG-3 ERPF (ml · min−1 · 1.73 m−2)270.7 ± 20.8276.3 ± 19.15.6 ± 14.9267.7 ± 21.5272.0 ± 20.24.3 ± 15−1.3 (−53 to 50)NS
FF (%)20.3 ± 1.219.7 ± 0.8−0.6 ± 1.220.2 ± 1.118.9 ± 0.7−1.3 ± 1.0−0.8 (−4.7 to 3.1)NS
PGC (mmHg)42.5 ± 2.641.0 ± 3.7−1.5 ± 2.039.0 ± 2.936.4 ± 3.3−2.5 ± 2.5−1.0 (−7.8 to 5.7)NS
  • Data means ± SEM or mean difference (95% CI).